MedPath

Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma

Phase 3
Conditions
Melanoma (Skin)
Interventions
Biological: pegylated interferon alfa
Procedure: adjuvant therapy
Registration Number
NCT00006249
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Brief Summary

RATIONALE: Interferon alfa may interfere with the growth of the cancer cells. It is not yet known if this treatment is more effective than observation following surgery for stage III melanoma.

PURPOSE: Randomized phase III trial to determine the effectiveness of interferon alfa in treating patients who have undergone surgery for stage III melanoma.

Detailed Description

OBJECTIVES:

* Compare the effect of adjuvant therapy with pegylated interferon alfa vs observation, in terms of distant metastases-free survival, in patients with previously resected stage III melanoma.

* Compare the overall survival in these patients after treatment with pegylated interferon alfa vs observation.

* Determine the toxicity of pegylated interferon alfa in these patients.

* Determine the compliance of these patients treated with pegylated interferon alfa.

* Compare the quality of life in these patients after treatment with pegylated interferon alfa vs observation.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to type of nodal involvement (N1 vs N2), number of positive nodes (1 vs 2-4 vs 5 or more vs not assessed), Breslow primary (T1-2 vs T3 vs T4 vs unknown), ulceration of primary tumor (absent vs present vs unknown), sex, and center. Patients are randomized to one of two treatment arms.

* Arm I: Patients receive pegylated interferon alfa subcutaneously weekly for 5 years.

* Arm II: Patients undergo observation only. Treatment continues in the absence of distant metastases or unacceptable toxicity.

Quality of life is assessed at baseline, and then at months 3, 12, 24, 36, 48, and 60.

Patients are followed every 6 months for 5 years.

PROJECTED ACCRUAL: A total of 1,200 patients (600 per treatment arm) will be accrued for this study within 1.5-2 years.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1258
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
pegylated interferon alfapegylated interferon alfa5 years pegylated interferon alfa + 5 years follow up
pegylated interferon alfaadjuvant therapy5 years pegylated interferon alfa + 5 years follow up
Primary Outcome Measures
NameTimeMethod
distant-metastasis free-survival (DMFS)from randomization

distant-metastasis free-survival (DMFS) after randomization

Secondary Outcome Measures
NameTimeMethod
toxicityfrom randomization

toxicity

survivalfrom randomization till death

duration of survival: time from randomization until death, whatever the cause

Trial Locations

Locations (103)

Vrije Universiteit Medisch Centrum

🇳🇱

Amsterdam, Netherlands

Leiden University Medical Center

🇳🇱

Leiden, Netherlands

David Maddison Clincial Sciences

🇦🇺

Newcastle, Australia

Institut Jules Bordet

🇧🇪

Brussels, Belgium

Hopital Universitaire Erasme

🇧🇪

Brussels, Belgium

National Centre of Oncology

🇧🇬

Sofia, Bulgaria

University Hospital Sestre Milosrdnice

🇭🇷

Zagreb, Croatia

CHR de Besancon - Hopital Saint-Jacques

🇫🇷

Besancon, France

Centre Hospitalier Universitare d'Amens

🇫🇷

Amiens, France

CHU Ambroise Pare

🇫🇷

Boulogne Billancourt, France

Hopital Saint Andre

🇫🇷

Bordeaux, France

CHR de Grenoble - La Tronche

🇫🇷

Grenoble, France

Centre Hospitalier Regional et Universitaire de Lille

🇫🇷

Lille, France

Centre Hospital Regional Universitaire de Limoges

🇫🇷

Limoges, France

Centre Leon Berard

🇫🇷

Lyon, France

Hopital L'Archet - 2

🇫🇷

Nice, France

Hopital St. Eloi

🇫🇷

Montpellier, France

Hopital Saint-Louis

🇫🇷

Paris, France

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle

🇫🇷

Montpellier, France

Hopital Bichat - Claude Bernard

🇫🇷

Paris, France

Hopital Haut Leveque

🇫🇷

Pessac, France

Centre Rene Huguenin

🇫🇷

Saint Cloud, France

Centre Alexis Vautrin

🇫🇷

Vandoeuvre-les-Nancy, France

Centre Hospitalier Universitaire

🇫🇷

Reims, France

Centre Eugene Marquis

🇫🇷

Rennes, France

Centre Hospitalier Regional Metz Thionville

🇫🇷

Thionville, France

Centre Hospitalier Universitaire Bretonneau de Tours

🇫🇷

Tours, France

Centre Hospitalier Regional et Universitaire de Saint-Etienne

🇫🇷

Saint Priest en Jarez, France

Institut Gustave Roussy

🇫🇷

Villejuif, France

Hopitaux Universitaire de Strasbourg

🇫🇷

Strasbourg, France

Saint Josef Hospital

🇩🇪

Bochum 1, Germany

Georg August Universitaet

🇩🇪

Goettingen, Germany

Universitaet Erlangen

🇩🇪

Erlangen, Germany

Stadt. Kliniken

🇩🇪

Dortmund, Germany

Robert Roessle Klinik

🇩🇪

Berlin, Germany

Haematologisch-Onkologische Praxis Altona

🇩🇪

Hamburg, Germany

Universitaets-Hautklinik Heidelberg

🇩🇪

Heidelberg, Germany

Universitaet Leipzig - Chirurgische Klinik und Poliklinik I

🇩🇪

Leipzig, Germany

Otto - Von - Guericke - Universitaet Magdeburg

🇩🇪

Magdeburg, Germany

Klinikum der Stadt Mannheim

🇩🇪

Mannheim, Germany

Universitaet Wuerzburg/Hautkrankheiten

🇩🇪

Wuerzburg, Germany

Rambam Medical Center

🇮🇱

Haifa, Israel

Wolfson Medical Center

🇮🇱

Holon, Israel

Tel-Aviv Sourasky Medical Center

🇮🇱

Tel-Aviv, Israel

Ospendale S.M. Annunziata-A.S.DI Firenze

🇮🇹

Firenze, Italy

Istituto Nazionale per la Ricerca sul Cancro

🇮🇹

Genoa (Genova), Italy

Centro di Riferimento Oncologico - Aviano

🇮🇹

Aviano, Italy

Universita Degli Studi di Torino

🇮🇹

Torino, Italy

European Institute of Oncology - Chemo Prevention

🇮🇹

Milano, Italy

Istituto Regina Elena

🇮🇹

Rome, Italy

University Medical Center Nijmegen

🇳🇱

Nijmegen, Netherlands

Erasmus University Medical Center

🇳🇱

Rotterdam, Netherlands

Academisch Ziekenhuis Utrecht

🇳🇱

Utrecht, Netherlands

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Clinico Universitario

🇪🇸

Zaragoza, Spain

Inselspital, Bern

🇨🇭

Bern, Switzerland

Vakif Gureba Training Hospital

🇹🇷

Istanbul, Turkey

Ege University Medical School

🇹🇷

Izmir, Turkey

Cheltenham General Hospital

🇬🇧

Cheltenham, England, United Kingdom

Royal Free Hospital

🇬🇧

London, England, United Kingdom

Guy's and St. Thomas' Hospitals NHS Trust

🇬🇧

London, England, United Kingdom

Weston Park Hospital

🇬🇧

Sheffield, England, United Kingdom

Ninewells Hospital and Medical School

🇬🇧

Dundee, Scotland, United Kingdom

Western Infirmary

🇬🇧

Glasgow, Scotland, United Kingdom

Selly Oak Hospital at University Hospital NHS Trust

🇬🇧

Birmingham, United Kingdom

Velindre Cancer Center at Velinde Hospital

🇬🇧

Cardiff, Wales, United Kingdom

Churchill Hospital

🇬🇧

Oxford, United Kingdom

Royal Perth Hospital

🇦🇺

Perth, Western Australia, Australia

Sir Charles Gairdner Hospital, Perth

🇦🇺

Perth, Western Australia, Australia

St. James's Hospital

🇬🇧

Leeds, England, United Kingdom

Saint Bartholomew's Hospital

🇬🇧

London, England, United Kingdom

Leicester Royal Infirmary

🇬🇧

Leicester, England, United Kingdom

Belfast City Hospital Trust

🇬🇧

Belfast, Northern Ireland, United Kingdom

Istituto Nazionale per lo Studio e la Cura dei Tumori

🇮🇹

Naples, Italy

Institute of Oncology, Ljubljana

🇸🇮

Ljubljana, Slovenia

Kantonspital Aarau

🇨🇭

Aarau, Switzerland

Great Poland Cancer Center

🇵🇱

Poznan, Poland

Instituto Portugues de Oncologia Centro do Porto, SA

🇵🇹

Porto, Portugal

Clatterbridge Centre for Oncology NHS Trust

🇬🇧

Merseyside, England, United Kingdom

Peter MacCallum Cancer Institute

🇦🇺

East Melbourne, Victoria, Australia

Addenbrooke's NHS Trust

🇬🇧

Cambridge, England, United Kingdom

Ratisches Kantons und Regionalspital

🇨🇭

Chur, Switzerland

North-Estonian Regional Hospital Cancer Centre

🇪🇪

Tallinn, Estonia

Instituto Portugues de Oncologia de Francisco Gentil - Centro de Lisboa

🇵🇹

Lisbon, Portugal

St. George's Hospital

🇬🇧

London, England, United Kingdom

Royal Marsden NHS Trust

🇬🇧

London, England, United Kingdom

Newcastle General Hospital

🇬🇧

Newcastle Upon Tyne, England, United Kingdom

Salisbury District Hospital

🇬🇧

Salisbury, England, United Kingdom

Royal Marsden Hospital

🇬🇧

Sutton, England, United Kingdom

Clinique Notre Dame de Grace

🇧🇪

Gosselies, Belgium

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology

🇵🇱

Warsaw, Poland

Austin and Repatriation Medical Centre

🇦🇺

Heidelberg West, Victoria, Australia

Cliniques Universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

Charles University Hospital

🇨🇿

Prague (Praha), Czech Republic

UniversitaetsSpital

🇨🇭

Zurich, Switzerland

Princess Royal Hospital

🇬🇧

Hull, England, United Kingdom

Bristol Haematology and Oncology Centre

🇬🇧

Bristol, England, United Kingdom

Royal Surrey County Hospital

🇬🇧

Guildford, England, United Kingdom

U.Z. Gasthuisberg

🇧🇪

Leuven, Belgium

Royal Devon and Exeter Hospital

🇬🇧

Exeter, England, United Kingdom

Southampton General Hospital

🇬🇧

Southampton, England, United Kingdom

Southend NHS Trust Hospital

🇬🇧

Westcliff-On-Sea, England, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath